Virtual Reality During Colonoscopy Procedures
Launched by UNIVERSITY OF PUERTO RICO · Jan 23, 2024
Trial Information
Current as of March 19, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The purpose of this study will be to evaluate the translation of VR into clinical practice for patients scheduled to receive a CRC screening through a colonoscopy. Findings from this study has widespread implications of translating VR technology to other patient populations and clinical settings during short procedures to improve outcomes. The specific aims will be to:
Aim 1. Determine the feasibility of implementing a VR distraction experience for patients during colonoscopy procedures using the RE-AlM framework. Using a mixed-methods approach, the investigators will evaluate participant ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Scheduled to receive a colonoscopy procedure
- • 21 years of age or older
- • Ability to read and speak in Spanish.
- Exclusion Criteria:
- • History of seizures
- • Balance disorder
- • Current infectious disease
- • Cognitive and visual impairments
- • Sedation intolerance
- • History of motion sickness.
Trial Officials
Sherily Pereira, PhD, FAAN
Principal Investigator
University of Puerto Rico, Medical Sciences Campus, School of Nursing
About University Of Puerto Rico
The University of Puerto Rico (UPR) is a leading academic institution dedicated to advancing research and education in various fields, including healthcare and clinical sciences. With a commitment to excellence, UPR conducts innovative clinical trials aimed at improving patient outcomes and addressing public health challenges. The university leverages its extensive resources, multidisciplinary expertise, and collaborative environment to foster groundbreaking research initiatives that contribute to the scientific community and enhance the well-being of the population it serves. Through its clinical trials, UPR aims to translate research findings into practical applications, ultimately driving progress in medical science and healthcare delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Related articles
